Clinical Trial Details
— Status: Active, not recruiting
Administrative data
NCT number |
NCT04867655 |
Other study ID # |
Glasgow University |
Secondary ID |
|
Status |
Active, not recruiting |
Phase |
N/A
|
First received |
|
Last updated |
|
Start date |
July 10, 2019 |
Est. completion date |
May 4, 2022 |
Study information
Verified date |
October 2021 |
Source |
University of Glasgow |
Contact |
n/a |
Is FDA regulated |
No |
Health authority |
|
Study type |
Interventional
|
Clinical Trial Summary
Brief summary Orange juice is the most widely consumed fruit juice, accounting for around a
third of the total fruit juice market and is a rich source of vitamin C and bioactive
compounds, predominantly flavonoids. Current research into the health effects of fruit juice
consumption has presented some conflicting conclusions. Although potential health benefits
have been attributed to the anti-inflammatory and anti-oxidant properties of the bioactive
components in juice, other studies have suggested that the benefits of consuming orange are
outweighed by the negative implications of the high sugar content leading to increases in
blood glucose and insulin. At the same time it is well established that supplementation with
a mean dose of 5g of β-Glucan, a soluble fibre derived from cereals such as oats or barley,
significantly reduces insulin and glucose in healthy subjects and metabolic compromised
individuals. Thus, the formulation of an OJ beverage with an added β-Glucan supplement may be
a useful strategy to attenuate the detrimental impact of high sugar content. However, while
delaying the absorption of glucose brings about favourable effects on post-prandial glycemia,
dietary fibre may also reduce the bioavailability of some beneficial compounds, including
polyphenols. So far, it remains unclear how addition of β-Glucan impacts bioavailability of
orange juice flavanones. Thus, this study aims to determine how the bioavailability of orange
juice polyphenols of healthy adults is affected mixing orange juice with 3 g and 6 g of oat
β-Glucan.
Description:
Brief summary Orange juice is the most widely consumed fruit juice, accounting for around a
third of the total fruit juice market and is a rich source of vitamin C and bioactive
compounds, predominantly flavonoids. Current research into the health effects of fruit juice
consumption has presented some conflicting conclusions. Although potential health benefits
have been attributed to the anti-inflammatory and anti-oxidant properties of the bioactive
components in juice, other studies have suggested that the benefits of consuming orange are
outweighed by the negative implications of the high sugar content leading to increases in
blood glucose and insulin. At the same time it is well established that supplementation with
a mean dose of 5g of β-Glucan, a soluble fibre derived from cereals such as oats or barley,
significantly reduces insulin and glucose in healthy subjects and metabolic compromised
individuals. Thus, the formulation of an OJ beverage with an added β-Glucan supplement may be
a useful strategy to attenuate the detrimental impact of high sugar content. However, while
delaying the absorption of glucose brings about favourable effects on post-prandial glycemia,
dietary fibre may also reduce the bioavailability of some beneficial compounds, including
polyphenols. So far, it remains unclear how addition of β-Glucan impacts bioavailability of
orange juice flavanones. Thus, this study aims to determine how the bioavailability of orange
juice polyphenols of healthy adults is affected mixing orange juice with 3 g and 6 g of oat
β-Glucan.
Eligible participants for this study will be healthy adults aged 18 - 50 years and with a BMI
in the normal or overweight to obese range (≥20 kg/m2). Participants will be required to be
non-smokers, with a stable weight for the previous 3 months, and not engage in regular
strenuous physical activity. Other exclusion criteria will include suffering from any chronic
disease, taking any medication, or following a special diet, including being vegetarian and
vegan. Before being enrolled in the study, potential participants will attend a health
screening session, in which they will complete a health screening and physical activity
questionnaire
This study will be a randomised controlled cross-over trial in which each participant will
complete two 24-h feeding trials. The experimental trials will be separated by a wash out
period of at least 7 days. The order of trials will be randomised for each participant, using
a random sequence generator. In the morning of the experimental trial participants will
consumed approximately 500ml of OJ (Tropicana 'with bits') without or with Oatwell fibre
supplement, providing either 6g or 3 g of β-Glucan. Blood samples and urinary fractions will
be collected prior to (baseline) and for 24 hours after consumption of corresponding
beverage. Participants will be asked to follow a special polyphenol-free diet and record
weighted dietary intake for 2 days preceding each trial and during the day of the
experimental trial.